We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688297:SSEAvic (Chengdu) UAS Co., Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥53.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

AVIC (Chengdu)UAS Co., Ltd. is trading at CNY 53.5, just below its 20‑day SMA of 54.49 but still above the 48.27 support level, indicating a modest near‑term cushion. The technical picture is mixed: a bullish overall trend contrasts with a bearish MACD histogram and a neutral RSI of 49, suggesting limited upside momentum in the short run. Fundamentally, the stock appears dramatically overvalued, with a trailing P/E of 594 versus an industry average of 29, and a price‑to‑book of 6.3, while profit margins are thin (gross margin 2.5%, operating margin 4.8%). The company’s balance sheet is strong on cash (CNY 3.54 bn) but carries a modest debt load, and it offers no dividend. Recent market sentiment has turned sharply positive for Chinese defence stocks after heightened Middle‑East tensions, lifting the CSI defence index by 3.4% on March 2, which provides a tailwind for AVIC’s export‑oriented UAV business. However, the stock’s 30‑day volatility of over 80% and a negative beta signal heightened price swings and limited correlation with broader market moves. Investors should weigh the defensive sector boost against the extreme valuation and volatile price action.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price just below 20‑day SMA, limiting immediate upside
  • Bearish MACD histogram and neutral RSI
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Bullish overall trend and strong cash position
  • Defence sector tailwinds from geopolitical tension
  • Persistently high valuation relative to earnings

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Long‑run growth potential in UAV export markets
  • Strategic importance of defence technology in China
  • Improving earnings outlook reflected in forward EPS guidance

Key Metrics & Analysis

Financial Health

Revenue Growth364.80%
Profit Margin2.94%
P/E Ratio594.4
ROE1.55%
Debt/Equity1.69
P/B Ratio6.3
Industry P/E29.3

Technical Analysis

TrendBullish
RSI49.1
SupportCN¥48.27
ResistanceCN¥65.41
MA 20CN¥54.49
MA 50CN¥51.77
MA 200CN¥50.38
MACDBearish
VolumeIncreasing
Fear & Greed Index81.63

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta-0.28
Volatility81.15%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.